Woodard & Company Asset Management Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-12,200
| Closed | -$815K | – | 100 |
|
|
2021
Q2 | $815K | Buy |
12,200
+917
| +8% | +$61.3K | 0.49% | 38 |
|
|
2021
Q1 | $712K | Buy |
11,283
+1,010
| +10% | +$63.7K | 0.45% | 40 |
|
|
2020
Q4 | $637K | Buy |
10,273
+786
| +8% | +$48.7K | 0.39% | 36 |
|
|
2020
Q3 | $577K | Buy |
9,487
+562
| +6% | +$34.2K | 0.38% | 35 |
|
|
2020
Q2 | $525K | Buy |
8,925
+802
| +10% | +$47.2K | 0.35% | 39 |
|
|
2020
Q1 | $453K | Buy |
+8,123
| New | +$453K | 0.33% | 38 |
|
|
2018
Q4 | – | Sell |
-300
| Closed | -$18K | – | 50 |
|
|
2018
Q3 | $18K | Hold |
300
| – | – | 0.02% | 131 |
|
|
2018
Q2 | $16.6K | Hold |
300
| – | – | 0.02% | 126 |
|
|
2018
Q1 | $19K | Hold |
300
| – | – | 0.02% | 121 |
|
|
2017
Q4 | $18K | Buy |
+300
| New | +$18K | 0.02% | 143 |
|